Skip to main content

Veraxa Biotech AG - Post de-SPAC

VRXAW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002079109

In the last 90 days, Veraxa Biotech AG - Post de-SPAC insiders filed 2 open-market purchases and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $992.5K in total; no superinvestor holds it.

Other share classesVRXA

13F holders, Q2 2026

Institutional positions in Veraxa Biotech AG - Post de-SPAC as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
27
+27 vs. Q1 2026
Shares held
8.54M
+8.54M vs. Q1 2026
Total value
$992.5K
+$992.5K vs. Q1 2026
New holders
27
0 more added
Sold out
0
0 more reduced

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VRXAW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 27 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 27 institutions
Value heldQ2 2026: $992.5K
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $992.5K
Institutions holding VRXAW and their total value by quarter
QuarterHoldersValue
Q2 202627$992.5K
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Veraxa Biotech AG - Post de-SPAC; share changes are against Q1 2026.

Institutions holding VRXAW in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
CSS LLC1,600,882$176.6K0.01%+1,600,882New
LMR Partners LLP1,089,100$120.1K0.00%+1,089,100New
Magnetar Financial LLC1,055,078$116.4K0.00%+1,055,078New
Aristeia Capital LLC976,083$115.7K0.00%+976,083New
Alberta Investment Management Corp875,000$96.5K0.00%+875,000New
CNH Partners LLC658,138$72.6K0.00%+658,138New
Clear Street Group Inc.485,358$53.5K0.00%+485,358New
JPMorgan Chase & Co–$43.8K0.00%–New
BNP Paribas Arbitrage, SA253,207$27.9K0.00%+253,207New
Whitebox Advisors LLC193,612$21.4K0.00%+193,612New
Wealthspring Capital LLC185,330$20.4K0.00%+185,330New
Westchester Capital Management, LLC183,647$20.3K0.00%+183,647New
Tenor Capital Management Co., L.P.150,000$16.5K0.00%+150,000New
Shaolin Capital Management LLC142,083$15.7K0.00%+142,083New
MMCAP International Inc. SPC125,000$13.8K0.00%+125,000New
Lineage Point Capital LP102,749$11.3K0.00%+102,749New
Context Capital Management, LLC100,000$11.0K0.00%+100,000New
Hudson Bay Capital Management LP100,000$11.0K0.00%+100,000New
Yakira Capital Management, Inc.98,360$10.8K0.00%+98,360New
Berkley W R Corp59,990$6.62K0.00%+59,990New
Verition Fund Management LLC43,672$4.82K0.00%+43,672New
Schonfeld Strategic Advisors LLC19,892$2.19K0.00%+19,892New
HRT Financial LP25,573$2.00K0.00%+25,573New
Susquehanna International Group, LLP10,267$1.13K0.00%+10,267New
Wolverine Asset Management LLC2,917$3220.00%+2,917New
Longfellow Investment Management Co LLC194$210.00%+194New
UBS Group AG1$00.00%+1New